{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:31:56Z","timestamp":1787740316953,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000094","name":"Ontario Ministry of Agriculture, Food and Rural Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.vaccine.2018.05.091","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T10:56:47Z","timestamp":1527677807000},"page":"4070-4076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["In ovo administration of Toll-like receptor ligands encapsulated in PLGA nanoparticles impede tumor development in chickens infected with Marek\u2019s disease virus"],"prefix":"10.1016","volume":"36","author":[{"given":"Jegarubee","family":"Bavananthasivam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiru N.","family":"Alkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Astill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Faizal","family":"Abdul-Careem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Wootton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Behboudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Yitbarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.091_b0005","series-title":"Marek\u2019s Dis. An Evol. Probl.","first-page":"62","article-title":"6 \u2013 Marek\u2019s disease virus: biology and life cycle","author":"Baigent","year":"2004"},{"key":"10.1016\/j.vaccine.2018.05.091_b0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nri2937","article-title":"Recognition of herpesviruses by the innate immune system","volume":"11","author":"Paludan","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.virol.2009.08.001","article-title":"Induction of innate host responses in the lungs of chickens following infection with a very virulent strain of Marek\u2019s disease virus","volume":"393","author":"Abdul-Careem","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.05.091_b0020","doi-asserted-by":"crossref","unstructured":"St. Paul M, Mallick AI, Haq K, Orouji S, Abdul-Careem MF, Sharif S. In vivo administration of ligands for chicken toll-like receptors 4 and 21 induces the expression of immune system genes in the spleen. Vet Immunol Immunopathol 2011; 144:228\u201337.","DOI":"10.1016\/j.vetimm.2011.09.004"},{"key":"10.1016\/j.vaccine.2018.05.091_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169154","article-title":"Characterization of innate responses induced by PLGA encapsulated- and soluble TLR ligands in vitro and in vivo in chickens","volume":"12","author":"Alkie","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.05.091_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.rvsc.2017.10.002","article-title":"Characterization of innate responses induced by in ovo administration of encapsulated and free forms of ligands of Toll-like receptor 4 and 21 in chicken embryos","author":"Bavananthasivam","year":"2017","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2018.05.091_b0035","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1089\/vim.2012.0033","article-title":"A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek\u2019s disease virus and hinders tumor development in chickens","volume":"25","author":"Parvizi","year":"2012","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0040","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.vaccine.2014.01.082","article-title":"The effects of administration of ligands for Toll-like receptor 4 and 21 against Marek\u2019s disease in chickens","volume":"32","author":"Parvizi","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.091_b0045","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3390\/v7041832","article-title":"In ovo delivery of CpG DNA reduces avian infectious laryngotracheitis virus induced mortality and morbidity","volume":"7","author":"Thapa","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2018.05.091_b0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.vetimm.2014.05.004","article-title":"CpG-ODNs induced changes in cytokine\/chemokines genes expression associated with suppression of infectious bronchitis virus replication in chicken lungs","volume":"160","author":"Dar","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/156720109787048221","article-title":"Enhancement of immunoprotective effect of CpG-ODN by formulation with polyphosphazenes against E. coli septicemia in neonatal chickens","volume":"6","author":"Taghavi","year":"2009","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.vaccine.2018.05.091_b0060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/ecp.11.5","article-title":"The pharmacokinectics of toll-like receptor agonists and the impact on the immune system","volume":"4","author":"Engel","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2018.05.091_b0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/03079458208436134","article-title":"Characterisation of two highly oncogenic strains of Marek\u2019s disease virus","volume":"11","author":"Schat","year":"1982","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jviromet.2005.10.018","article-title":"Development of a real-time PCR assay using SYBR green chemistry for monitoring Marek\u2019s disease virus genome load in feather tips","volume":"133","author":"Abdul-Careem","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2018.05.091_b0080","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/eji.200838866","article-title":"Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex","volume":"39","author":"Komai-Koma","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4049\/jimmunol.1203334","article-title":"Targeting of toll-like receptors inhibits CD4+ regulatory T cell function and activates lymphocytes in human PBMCs","volume":"193","author":"Voo","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.12659\/MSM.902081","article-title":"Toll-like receptor 4 signaling in high mobility group Box-1 protein 1 mediated the suppression of regulatory T-cells","volume":"23","author":"Luo","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.vaccine.2018.05.091_b0095","doi-asserted-by":"crossref","first-page":"e1006745","DOI":"10.1371\/journal.ppat.1006745","article-title":"Association of Marek\u2019s Disease induced immunosuppression with activation of a novel regulatory T cells in chickens","volume":"13","author":"Gurung","year":"2017","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.vaccine.2018.05.091_b0100","doi-asserted-by":"crossref","first-page":"9816","DOI":"10.1158\/0008-5472.CAN-10-1251","article-title":"Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma","volume":"70","author":"Brignole","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2018.05.091_b0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1078-0432.CCR-05-1943","article-title":"Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors","volume":"12","author":"Damiano","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2018.05.091_b0110","doi-asserted-by":"crossref","unstructured":"Kabilova TO, Sen\u2019kova AV, Nikolin VP, Popova NA, Zenkova MA, Vlassov V V, et al. Antitumor and antimetastatic effect of small immunostimulatory RNA against B16 Melanoma in Mice. PLoS One 2016; 11:1\u201317","DOI":"10.1371\/journal.pone.0150751"},{"key":"10.1016\/j.vaccine.2018.05.091_b0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1189\/jlb.5RU0714-360RR","article-title":"Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP","volume":"97","author":"Fabbi","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbcan.2013.09.001","article-title":"Interleukin 18: friend or foe in cancer","volume":"1836","author":"Palma","year":"2013","journal-title":"Biochim Biophys Acta - Rev Cancer"},{"key":"10.1016\/j.vaccine.2018.05.091_b0125","first-page":"1664","article-title":"Antitumor actions of interferon-gamma and interleukin-1 beta on human papillary thyroid carcinoma cell lines","volume":"80","author":"Yip","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.vaccine.2018.05.091_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13238-013-0001-4","article-title":"Inflammasomes in cancer: a double-edged sword","volume":"5","author":"Kolb","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.vaccine.2018.05.091_b0135","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.05.091_b0140","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-8-72","article-title":"CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo","volume":"8","author":"Knuefermann","year":"2007","journal-title":"Respir Res"},{"key":"10.1016\/j.vaccine.2018.05.091_b0145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1189\/jlb.0312132","article-title":"NLRs, inflammasomes, and viral infection","volume":"92","author":"Jacobs","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0150","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/JVI.77.2.953-962.2003","article-title":"A Protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection","volume":"77","author":"Harandi","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0155","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jlb.64.4.519","article-title":"Interleukin-18\/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells","volume":"64","author":"Kohka","year":"1998","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0160","doi-asserted-by":"crossref","first-page":"10002","DOI":"10.1128\/JVI.01486-14","article-title":"Activation of NF-\u03baB via Endosomal Toll-Like Receptor 7 (TLR7) or TLR9 Suppresses Murine Herpesvirus 68 Reactivation","volume":"88","author":"Haas","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.onc.1210910","article-title":"TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours","volume":"27","author":"Conroy","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.vaccine.2018.05.091_b0170","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1128\/JVI.00457-11","article-title":"Type I interferon contributes to CD4+ T cell depletion induced by infection with HIV-1 in the human thymus","volume":"85","author":"Sivaraman","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0175","doi-asserted-by":"crossref","unstructured":"Cheng L, Yu H, Li G, Li F, Ma J, Li J, et al. Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection. JCI Insight 2017; 2.","DOI":"10.1172\/jci.insight.94366"},{"key":"10.1016\/j.vaccine.2018.05.091_b0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002810000028","article-title":"Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons","volume":"22","author":"Sun","year":"2000","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.addr.2008.12.008","article-title":"Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists","volume":"61","author":"Vollmer","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2018.05.091_b0190","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1084\/jem.188.12.2335","article-title":"Type I interferon-mediated stimulation of T cells by CpG DNA","volume":"188","author":"Sun","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.05.091_b0195","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.4049\/jimmunol.169.7.3892","article-title":"Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model","volume":"169","author":"Heckelsmiller","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0205","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.dci.2007.09.003","article-title":"Gene expression profiling of chicken lymphoid cells after treatment with Lactobacillus acidophilus cellular components","volume":"32","author":"Brisbin","year":"2008","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.virol.2008.06.027","article-title":"Host responses in the bursa of Fabricius of chickens infected with virulent Marek\u2019s disease virus","volume":"379","author":"Abdul-Careem","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.05.091_b0215","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1128\/CVI.00143-10","article-title":"Effects of lactobacilli on cytokine expression by chicken spleen and cecal tonsil cells","volume":"17","author":"Brisbin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/vim.2006.19.167","article-title":"Marek\u2019s disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system","volume":"19","author":"Abdul-Careem","year":"2006","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2018.05.091_b0225","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.vaccine.2006.08.006","article-title":"Cytokine gene expression patterns associated with immunization against Marek\u2019s disease in chickens","volume":"25","author":"Abdul-Careem","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:34:06Z","timestamp":1569976446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18307576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":45,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0264410X18307576"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.091","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In ovo administration of Toll-like receptor ligands encapsulated in PLGA nanoparticles impede tumor development in chickens infected with Marek\u2019s disease virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}